ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

A Clinical Signature Surrogate of Histological Lesions to Avoid Unnecessary One Year Surveillance Biopsy After Renal Transplantation

E. Dantan, K. Renaudin, S. Brouard, A. Huneau, C. Paul, M. Giral.

Biostatitics, Nantes University, Nantes, France
Anatomo Pathology, University Hospital, Nantes, France
Immunology, Inserm UMR1064, Nantes, France
Biostatistics, Nantes University, Nantes, France
Immunology, Inserm UMR1064, Nantes, France
Nephrology, University Hospital, Nantes, France.

Meeting: 2015 American Transplant Congress

Abstract number: A40

Keywords: Histology, Protocol biopsy

Session Information

Session Name: Poster Session A: Delayed Function/Acute Injury/Outcomes/Glomerulonephritis

Session Type: Poster Session

Date: Saturday, May 2, 2015

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Exhibit Hall E

Introduction:

Surveillance biopsy remains debated after renal transplantation since the histological diagnostic do not lead to clear therapeutic recommendations. The main objective for this study was to identify and validate a clinical diagnostic signature of histological lesions from surveillance biopsy at one year after renal transplantation.

Patients and methods:

From the DIVAT cohort, we studied 567 adult recipients of kidney or kidney-pancreas, transplanted between 2006 and 2012, from deceased donor, and alive with a functioning graft at one year post-transplantation. Patients displaying major histological lesions comprising “allo-immunity” (i.e. Borderline, acute or chronic humoral and/or cellular rejection), IFTA grade 2 or 3 and initial disease relapse were compared with patients presenting minor lesions (i.e. Normal histology or IFTA grade 1). The diagnostic signature was identified using a lasso penalized logistic regression and internally validated by ROC 0.632+ bootstrap.

Results:

303 patients (53%) were diagnosed with minor histological lesions. The diagnostic signature included 8 variables. Women recipients (OR=2.70), patients with a kidney transplant alone (OR=1.36), with high serum creatinine at 3 months (OR=1.05), 6 months (OR=1.58) and 12 months (OR=1.42), receiving a male kidney (OR=1.48), with anti-class II immunization at transplantation time (OR=1.47) and who experienced dialysis before transplantation (OR=2.81) are more at risk of major histological lesions. The area under the associated ROC curve is estimated at 0.69. We assumed a minimal negative predictive value at 75% leading to a discriminating threshold. In this medical decision making perspective, 17% of patients have a good chance to display minor lesions and a surveillance biopsy should not be proposed.

Conclusion:

This diagnostic signature can help physicians to not recommend surveillance biopsies in patients at high risk of minor lesions and therefore avoid unnecessary biopsies.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Dantan E, Renaudin K, Brouard S, Huneau A, Paul C, Giral M. A Clinical Signature Surrogate of Histological Lesions to Avoid Unnecessary One Year Surveillance Biopsy After Renal Transplantation [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/a-clinical-signature-surrogate-of-histological-lesions-to-avoid-unnecessary-one-year-surveillance-biopsy-after-renal-transplantation/. Accessed May 31, 2025.

« Back to 2015 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences